Induction of haematological and cytogenetic remission by marrow donor lymphocyte infusion in a patient with relapsed chronic myelogenous leukemia after second allogeneic bone marrow transplantation
Gorski, P.; Gozdzik, J.; Balcerzak, A.; Kroll, R.; Hansz, J.
Acta Haematologica Polonica 28(4): 453-458
1997
ISSN/ISBN: 0001-5814 Accession: 008857936
Bone marrow donor lymphocyte infusion in the total dose of 6,8 X 108 cells/kg was administered in a 42-year old man with chronic myelogenous leukemia who had relapsed after second HLA-matched allogeneic bone marrow transplantation. A complete haematological and cytogenetic remission occurred after 10 and 16 weeks respectively in the absence of clinical symptoms of graft versus host disease. The patient is now 14 months post lymphocyte infusion and remains in remission although bcr-abl transcript is detectable.
PDF emailed within 1 workday: $29.90
Related References
Giralt, S.; Hester, J.; Huh, Y.; Hirsch-Ginsberg, C.; Rondón, G.; Seong, D.; Lee, M.; Gajewski, J.; Van Besien, K.; Khouri, I.; Mehra, R.; Przepiorka, D.; Körbling, M.; Talpaz, M.; Kantarjian, H.; Fischer, H.; Deisseroth, A.; Champlin, R. 1995: CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Blood 86(11): 4337-4343Inai, K.; Wano, Y.; Yamamoto, S.; Ikebata, Y.; Iwasaki, H.; Tsutani, H.; Naiki, H.; Ueda, T. 1999: Molecular remission induced by fractionated dose-escalating donor leukocyte infusion without graft-versus-host disease in a patient with chronic myelogenous leukemia relapsed after allogeneic bone marrow transplantation Anticancer Research 19(6c): 5631-5634
Hoff, M.; Giralt, S.; Huh, Y.; Rondon, G.; Gajewski, J.; Ueno, N.; Claxton, D.; Mirza, N.; Davis, M.; Van Basien, K.; Khouri, I.; Rehra, R.; Przepiorka, D.; Korbling, M.; Talpaz, M.; Kantarjian, H.; Champlin, R. 1997: Long term follow up of CD8-depleted donor lymphocyte infusion An effective treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Blood 90(10 Suppl 1 Pt 1): 102A
Giralt, S.; Hester, J.; Huh, Y.; Hirsch Ginsberg, C.; Rondon, G.; Guo, J.; Lee, M.; Gajewski, J.; Talpaz, M.; Kantarjian, H.; Fischer, H.; Deisseroth, A.; Champlin, R. 1994: CD8+ depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Graft vs leukemia without graft vs host disease Blood 84(10 Suppl 1): 538A
Drobyski, W.R.; Roth, M.S.; Thibodeau, S.N.; Gottschall, J.L. 1992: Molecular remission occuring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Bone Marrow Transplantation (Basingstoke) 10(3): 301-304
Drobyski, W.R.; Roth, M.S.; Thibodeau, S.N.; Gottschall, J.L. 1992: Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Bone Marrow Transplantation 10(3): 301-304
Drobyski, W.R.; Roth, M.S.; Thibodeau, S.N.; Gottschall, J.L. 1992: Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Bone Marrow Transplantation 10(3): 301-304
Voltarelli, J.; Palma, P.; Morais, F.; Castro, F. 2004: Immunological effects of donor lymphocyte infusion in patients with chronic myelogenous leukemia relapsing after allogeneic bone marrow transplantation Biology of Blood and Marrow Transplantation 10: 53-54
Leda, M.; Ladon, D.; Pieczonka, A.; Boruczkowski, D.; Jólkowska, J.; Witt, M.; Wachowiak, J. 2001: Donor lymphocyte infusion followed by interferon-alpha plus low dose cyclosporine A for modulation of donor CD3 cells activity with monitoring of minimal residual disease and cellular chimerism in a patient with first hematologic relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation Leukemia Research 25(4): 353-357
Maeda, A.; Yamamoto, K.; Kotone, Y.; Yamashita, K.; Yoshinaga, N.; Hirata, H.; Asagoe, K.; Nohgawa, M.; Takahashi, A.; Ohno, H.; Tashima, M.; Sasada, M. 1998: Successful treatment with donor leukocyte transfusion followed by interferon-alpha in a patient with relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Japanese Journal of Clinical Hematology 39(6): 442-446
Ookura, M.; Yamauchi, T.; Negoro, E.; Hosono, N.; Kishi, S.; Inai, K.; Wano, Y.; Matsumoto, K.; Iwasaki, H.; Morita, K.; Ueda, T. 2014: Sudden blast crisis of chronic myeloid leukemia after a 13-year durable remission following allogeneic bone marrow transplantation and donor lymphocyte infusion Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(2): 265-268
Fujimaki, K.; Maruta, A.; Yoshida, M.; Yamazaki, E.; Matsuzaki, M.; Fujisawa, S.; Kanamori, H.; Ishigatsubo, Y. 2001: Complete cytogenetic response obtained with unrelated donor lymphocyte infusion for relapse of chronic myeloid leukemia in blastic crisis after allogeneic bone marrow transplantation Japanese Journal of Clinical Hematology 42(3): 204-208
Ishikawa, J.; Maeda, T.; Kashiwagi, H.; Yoshida, H.; Takahashi, I.; Kawamoto, S-I.; Yamada, M.; Kato, H.; Nishiura, T.; Tomiyama, Y.; Matsuzawa, Y. 2003: Successful second allogeneic peripheral blood stem cell transplantation and donor lymphocyte infusion in patients with relapsed acute leukemia using the same donors as for the initial allogeneic bone marrow transplantation Bone Marrow Transplantation 31(11): 1057-1059
Itoh, T.; Hatta, Y.; Miyajima, T.; Simojima, H.; Sawada, U.; Horie, T. 1998: Donor leukocyte transfusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Japanese Journal of Clinical Hematology 39(6): 409-415
Miyamoto, T.; Fukuda, T.; Nakashima, M.; Henzan, T.; Kusakabe, S.; Kobayashi, N.; Sugita, J.; Mori, T.; Kurokawa, M.; Mori, S-Ichiro. 2017: Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 23(6): 938-944
Slavin, S.; Naparstek, E.; Nagler, A.; Ackerstein, A.; Kapelushnik, Y.; Varadi, G.; Kirschbaum, M.; Ben Yosef, R.; Samuel, S.; Or, R. 1996: Successful control of relapsed leukemia resistant to allogeneic bone marrow transplantation and donor lymphocyte infusion with rIL-2-activated donor-derived blood lymphocytes Blood 88(10 Suppl 1 Part 1-2): 259A
Gopcsa, László.; Barta, Aó.; Bányai, Aó.; Dolgos, János.; Halm, G.; Pálóczi, K. 2003: Salvage chemotherapy with donor lymphocyte infusion and STI 571 in a patient relapsing with B-lymphoblastic phase chronic myeloid leukemia after allogeneic bone marrow transplantation Pathology Oncology Research: Por 9(2): 131-133
Slavin, S.; Ackerstein, A.; Morecki, S.; Gelfand, Y.; Cividalli, G. 2001: Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes Bone Marrow Transplantation 28(8): 795-798
Agaliotis, D.P.; Papenhausen, P.R.; Moscinski, L.C.; Elfenbein, G.J. 1995: Case report of spontaneous remission of cytogenetic relapse of chronic myelogenous leukemia suggestive of progression to blast crisis after allogeneic bone marrow transplantation Annals of Hematology 70(1): 37-41
Sehn, L.H.; Alyea, E.P.; Weller, E.; Canning, C.; Lee, S.; Ritz, J.; Antin, J.H.; Soiffer, R.J. 1999: Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 17(2): 561-568